Professor Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare and is practicing at numerous locations including The LOC, The Harley Street Clinic, The Princess Grace, and The Wellington Hospital. He is also serving as a Chief Medical Officer and Global Head of Drug Development at Ellipses Pharma, a London-based biotech focusing on cancer drug development.
He was founding Medical Director of the Sarah Cannon Research Institute UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. He is holding an honorary Professorship at University College London Hospital.
Prof Arkenau has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. He was awarded his medical degree from Hannover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his research contributions to his field. During his career, he has published numerous peer reviewed articles and book chapters and contributes regularly at international meetings such as ASCO, ESMO and AACR.
Events/Masterclasses Tobias Arkenau is currently speaking at
Finance
Life & Health Insurance Summit
15 – 16 May 2024
Mercure Amsterdam City Hotel, The Netherlands
Life & Health Insurance Summit - the great reset to endure and flourish in the years ahead.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Professor Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare and is practicing at numerous locations including The LOC, The Harley Street Clinic, The Princess Grace, and The Wellington Hospital. He is also serving as a Chief Medical Officer and Global Head of Drug Development at Ellipses Pharma, a London-based biotech focusing on cancer drug development.
He was founding Medical Director of the Sarah Cannon Research Institute UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. He is holding an honorary Professorship at University College London Hospital.
Prof Arkenau has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. He was awarded his medical degree from Hannover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his research contributions to his field. During his career, he has published numerous peer reviewed articles and book chapters and contributes regularly at international meetings such as ASCO, ESMO and AACR.
